HLA-A*0201 Tyrosinase Tetramer-YMDGTMSQV-PE

MBL Life Sciences

Catalog No.: MBL-TS-0019-1C

The α3 mutation significantly reduces the binding of MHC tetramer to human CD8. To minimizes the aberrant effect of some CD8 antibodies; clone SFCI21Thy2D3 (also known as “T8”) is recommended.

Product Specifications

• Application: FC
• Reactivity: Human
• Conjugation: PE
• Immunogen: Tyrosinase
• Peptide Sequence: YMDGTMSQV
• Class: Class I
• Sequence Location: 368-376
• MHC Allele: A*02:01

Citations for HLA-A*0201 Tyrosinase Tetramer-YMDGTMSQV-PE – 1 Found

Akiyama, Yasuto; Tanosaki, Ryuji; Inoue, Naoki; Shimada, Makiko; Hotate, Yukie; Yamamoto, Akifumi; Yamazaki, Naoya; Kawashima, Ichiro; Nukaya, Ikuei; Takesako, Kazutoh; Maruyama, Kouji; Takaue, Yoichi; Yamaguchi, Ken. Clinical response in Japanese metastatic melanoma patients treated with peptide cocktail-pulsed dendritic cells. Journal Of Translational Medicine. 2005;3(1):4.